PRS, Inc., headquartered in Princeton, New Jersey, USA, is a privately held company that specializes in global regulatory and pharmacovigilance intelligence and consulting. We monitor pharmacovigilance intelligence information in more than 150 countries globally and provide access to a user-friendly online database which provides information organized into various modules - pre- and post-authorization pharmacovigilance requirements (expedited and periodic reporting), local requirements for QPPVs, as well as regulatory requirements for compassionate use. PRS subject matter experts with years of experience within global pharmacovigilance intelligence landscape monitor publicly available global information sources, identify new and changed documents/information in local languages, assess relevance of changes and prepare brief summary notifications in English that provide references and links to guidance documents in original languages. Notifications are distributed in real-time to named users via e-mail. In addition, they are stored in the database Notifications section for future reference. The modules are updated weekly.